CN Stock MarketDetailed Quotes

600535 Tasly Pharmaceutical Group

Watchlist
  • 13.18
  • +0.07+0.53%
Trading Jul 22 14:27 CST
19.69BMarket Cap17.88P/E (TTM)

Tasly Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tasly Pharmaceutical Group Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

2.05B

-1.73%
EPS(YoY)

0.20

+12.74%
Analyst Rating

Strong Buy

Jul 22, 2024

Tasly Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.471B--
Aug 24, 20242024/Q2-- / 2.541B--
--2024/Q12.049B / 2.208B--
--2023/Q42.103B / 2.709B--
--2021/Q11.764B / 1.589B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.471B--
Aug 24, 20242024/Q2-- / 2.541B--
--2024/Q12.049B / 2.208B--
--2023/Q42.103B / 2.709B--
--2021/Q11.764B / 1.589B--

Unlock Free Earnings Estimates

Tasly Pharmaceutical Group Earnings Reports

  • Tasly 2024 First Quarter Report

    Apr 25 12:00 ET

  • Tasly 2023 Annual Report

    Apr 15 12:00 ET

  • Tasly 2023 Annual Report Summary

    Apr 15 12:00 ET

  • Tessile\'s 2023 Annual Results Forecast

    Jan 18 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Strong Buy

    • Strong Buy

      81.82%

    • Buy

      18.18%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg